Cullinan Therapeutics (CGEM) Current Taxes (2022 - 2023)
Cullinan Therapeutics' (CGEM) quarterly Current Taxes came in at $4.2 million in Q1 2023, down 1.75% quarter-over-quarter from $4.3 million in Q4 2022.
Cullinan Therapeutics (CGEM) Current Taxes (2022 - 2023) Analysis & Trends
Cullinan Therapeutics' Current Taxes history runs 2 years deep, the most recent figure standing at $4.2 million for Q1 2023.
- On a quarterly basis, Current Taxes changed N/A year-over-year to $4.2 million in Q1 2023; TTM through Mar 2023 was $4.2 million, a N/A change from a year earlier, with the FY2022 full-year figure at $4.3 million, changed N/A from the prior year.
- Current Taxes slipped to $4.2 million in Q1 2023 per CGEM's latest filing, from $4.3 million in the prior quarter.
- Across five years, Current Taxes topped out at $46.5 million in Q2 2022 and bottomed at $4.2 million in Q1 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 63.52 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 49.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Cullinan Therapeutics | 368.65 Mn | 368.65 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2023 | 4.21 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 11.40 Mn |
| Jun 30, 2022 | 46.50 Mn |